What is Vor Biopharma's net investment in lease?

Vor Biopharma (VOR) reported net investment in lease of $2.83M in Q1 2026.

How has Vor Biopharma's net investment in lease changed year-over-year?

Vor Biopharma's net investment in lease decreased by 91.6% year-over-year, from $33.7M to $2.83M.

What is the long-term trend for Vor Biopharma's net investment in lease?

Over 5 years (2020 to 2025), Vor Biopharma's net investment in lease has grown at a -29.7% compound annual growth rate (CAGR), from $17.12M to $2.94M.

Vor Biopharma VOR Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

Dianthus TherapeuticsDNTH

——

Cullinan Therapeutics, Inc.CGEM

——

Design Therapeutics, Inc.DSGN

——

Avalo TherapeuticsAVTX

——

Janux TherapeuticsJANX

——

Other financials

Income statement

See full

Operating income-$35.2M-5.6%

Net income-$219.6M-576%

EPS (diluted)-$5.11+1.9%

Balance sheet

See full

Cash & equivalents$169.9M+239%

Total debt$2.9M-90.5%

Total equity-$150.4M-328%

Total assets$506.7M+364%

Cash flow

See full

Operating cash flow-$38.2M-23.1%

CapEx$48.0K-79.2%

Free cash flow-$38.3M-22.4%

Valuation

See full

Market cap$784.61M+2,513%

Enterprise value$617.68M+5,639%

Returns & leverage

See full

Return on equity-125.4%+671pp

Debt / equity0.5×+0.2×

Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vor Biopharma's net investment in lease?: Vor Biopharma (VOR) reported net investment in lease of $2.83M in Q1 2026.
How has Vor Biopharma's net investment in lease changed year-over-year?: Vor Biopharma's net investment in lease decreased by 91.6% year-over-year, from $33.7M to $2.83M.
What is the long-term trend for Vor Biopharma's net investment in lease?: Over 5 years (2020 to 2025), Vor Biopharma's net investment in lease has grown at a -29.7% compound annual growth rate (CAGR), from $17.12M to $2.94M.